480 related articles for article (PubMed ID: 18425130)
1. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW
Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic modifiers of long-term survival in heart failure.
Cresci S; Kelly RJ; Cappola TP; Diwan A; Dries D; Kardia SL; Dorn GW
J Am Coll Cardiol; 2009 Jul; 54(5):432-44. PubMed ID: 19628119
[TBL] [Abstract][Full Text] [Related]
3. GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
Kurnik D; Cunningham AJ; Sofowora GG; Kohli U; Li C; Friedman EA; Muszkat M; Menon UB; Wood AJ; Stein CM
Pharmacogenomics; 2009 Oct; 10(10):1581-7. PubMed ID: 19842931
[TBL] [Abstract][Full Text] [Related]
4. Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure.
Zhang Y; Matkovich SJ; Duan X; Gold JI; Koch WJ; Dorn GW
Circ Heart Fail; 2011 Sep; 4(5):659-68. PubMed ID: 21768220
[TBL] [Abstract][Full Text] [Related]
5. Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.
Kang S; Hong X; Ruan CW; Yu P; Yu SS; Chen M; Zhang DF; Fan HM; Liu ZM
J Transl Med; 2015 Feb; 13():44. PubMed ID: 25638254
[TBL] [Abstract][Full Text] [Related]
6. A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors.
Wang WC; Mihlbachler KA; Bleecker ER; Weiss ST; Liggett SB
Pharmacogenet Genomics; 2008 Aug; 18(8):729-32. PubMed ID: 18622265
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled receptor kinases in normal and failing myocardium.
Huang ZM; Gold JI; Koch WJ
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic signaling in heart failure-adapt or die.
Eschenhagen T
Nat Med; 2008 May; 14(5):485-7. PubMed ID: 18463653
[No Abstract] [Full Text] [Related]
10. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.
Iaccarino G; Tomhave ED; Lefkowitz RJ; Koch WJ
Circulation; 1998 Oct; 98(17):1783-9. PubMed ID: 9788834
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.
Cohn HI; Xi Y; Pesant S; Harris DM; Hyslop T; Falkner B; Eckhart AD
Hypertension; 2009 Jul; 54(1):71-6. PubMed ID: 19487588
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.
Dorn GW; Liggett SB
Clin Transl Sci; 2008 Dec; 1(3):255-62. PubMed ID: 20443857
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.
Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H
Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of heart failure.
Lymperopoulos A; French F
Methods Mol Biol; 2014; 1175():245-57. PubMed ID: 25150872
[TBL] [Abstract][Full Text] [Related]
17. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart.
Eckhart AD; Duncan SJ; Penn RB; Benovic JL; Lefkowitz RJ; Koch WJ
Circ Res; 2000 Jan 7-21; 86(1):43-50. PubMed ID: 10625304
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
de Lucia C; Grisanti LA; Borghetti G; Piedepalumbo M; Ibetti J; Lucchese AM; Barr EW; Roy R; Okyere AD; Murphy HC; Gao E; Rengo G; Houser SR; Tilley DG; Koch WJ
Cardiovasc Res; 2022 Jan; 118(1):169-183. PubMed ID: 33560342
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies.
Pitcher JA; Fredericks ZL; Stone WC; Premont RT; Stoffel RH; Koch WJ; Lefkowitz RJ
J Biol Chem; 1996 Oct; 271(40):24907-13. PubMed ID: 8798768
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.
Johnson AE; Hanley-Yanez K; Yancy CW; Taylor AL; Feldman AM; McNamara DM
J Card Fail; 2019 Jul; 25(7):553-560. PubMed ID: 30978507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
